Mark D. Lindner

Mark D. Lindner

Auto-generated profile, based on publicly available information

Mark D. Lindner

Center for Scientific Review, National Institutes of Health, Bethesda, Maryland, United States of America

Research Focus & Metrics

Academic Career Length

44Years (1983-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 1996 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
DEDwaine F. Emerich
Dwaine F. Emerich
MLMark D. Lindner
Mark D. Lindner
SWShelley R. Winn
Shelley R. Winn
ECEr-Yun Chen
Er-Yun Chen
BFBeata R. Frydel
Beata R. Frydel
JKJeffrey H. Kordower
Jeffrey H. Kordower
Delivery of neurotrophic molecules to the CNS has gained considerable attention as a potential treatment strategy for neurological disorders. In the present study, a DHFR-based expression vector containing the human ciliary neurotrophic factor (hCNTF) was transfected into a baby hamster kidney fibroblast cell line (BHK). Using a polymeric device, encapsulated BHK-control cells and those secreting hCNTF (BHK-hCNTF) were transplanted unilaterally into the rat lateral ventricle. Twelve days later, the same animals received unilateral injections of quinolinic acid (QA; 225 nmol) into the ipsilateral striatum. After surgery, animals were behaviorally tested for apomorphine-induced rotation behavior and for skilled forelimb function using the staircase test. Rats receiving BHK-hCNTF cells rotated significantly less than animals receiving BHK-control cells. No behavioral effects of hCNTF were observed on the staircase test. Nissl-stained sections demonstrated that BHK-hCNTF cells significantly reduced the extent of striatal damage produced by QA. Quantitative analysis of striatal neurons further demonstrated that both choline acetyltransferase- and GAD-immunoreactive neurons were protected by BHK-hCNTF implants. In contrast, a similar loss of NADPH-diaphorase-positive cells was observed in the striatum of both implant groups. Analysis of retrieved capsules revealed numerous viable and mitotically active BHK cells that continued to secrete hCNTF. These results support the concepts that implants of polymer-encapsulated hCNTF-releasing cells can be used to protect striatal neurons from excitotoxic damage and that this strategy may ultimately prove relevant for the treatment of Huntington’s disease.

1 November 1997 in Neurobiology of Learning and Memory
Verified
Journal Article
Closed access
MLMark D Lindner
Mark D Lindner

5 June 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
EEElena A. Erosheva
Elena A. Erosheva
SGSheridan Grant
Sheridan Grant
MCMei-Ching Chen
Mei-Ching Chen
MLMark D. Lindner
Mark D. Lindner
RNRichard K. Nakamura
Richard K. Nakamura
CLCarole J. Lee
Carole J. Lee
Black-white disparities in preliminary peer review scores for NIH R01 grant applications are examined.

1 March 1995 in Experimental Neurology
Verified
Journal Article
Closed access
MLMark D. Lindner
Mark D. Lindner
SWShelley R. Winn
Shelley R. Winn
EBE.E. Baetge
E.E. Baetge
JHJoseph P. Hammang
Joseph P. Hammang
FGFrank T. Gentile
Frank T. Gentile
DEDwaine F. Emerich
Dwaine F. Emerich

26 November 2003 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
MLMark D. Lindner
Mark D. Lindner
VGValentin K. Gribkoff
Valentin K. Gribkoff
NDNicole A. Donlan
Nicole A. Donlan
TJTheresa A. Jones
Theresa A. Jones
Recommendations from experts and recently established guidelines on how to improve the face and predictive validity of animal models of stroke have stressed the importance of using older animals and long-term behavioral-functional endpoints rather than relying almost exclusively on acute measures of infarct volume in young animals. The objective of the present study was to determine whether we could produce occlusions in older rats with an acceptable mortality rate and then detect reliable, long-lasting functional deficits. A reversible intraluminar suture middle cerebral artery occlusion (MCAO) procedure was used to produce small infarcts in middle-aged rats. This resulted in an acceptable mortality rate, and robust disabilities were detected in functional assays, although the degree of total tissue loss measured 90 d after MCAO was quite modest. Infarcted animals were functionally impaired relative to sham control animals even 90 d after the occlusions, and when animals were subgrouped based on amount of tissue loss, MCAO animals with only 4% tissue loss exhibited enduring neurological-behavioral impairments relative to sham-operated controls, and the functional impairments in the group with the largest infarcts (20% tissue loss) were more severe than the functional impairments in the rats with 4% tissue loss. These results suggest that this model, using reversible MCAO to produce small infarcts and long-lasting functional-behavioral deficits in older rats, may represent an advance in the relatively higher-throughput modeling of stroke and its recovery in rodents and may be useful in the development and characterization of future stroke therapies.

1 March 1998 in Journal of Neurotrauma
Verified
Journal Article
Closed access
MLMark D. Lindner
Mark D. Lindner
MPMelissa A. Plone
Melissa A. Plone
CCChris K. Cain
Chris K. Cain
BFBeata Frydel
Beata Frydel
JFJonathan M. Francis
Jonathan M. Francis
RSRichard L. Sutton
Richard L. Sutton
Cognitive deficits are the most enduring and disabling sequelae of human traumatic brain injury (TBI), but quantifying the magnitude, duration, and pattern of cognitive deficits produced by different types of TBI has received little emphasis in preclinical animal models. The objective of the present study was to use a battery of behavioral tests to determine if different impact sites produce different patterns of behavioral deficits and to determine how long behavioral deficits can be detected after TBI. Prior to surgery, rats were trained to criteria on delayed nonmatching to position, radial arm maze, and rotarod tasks. Rats received sham surgery (controls), midline frontal contusions (frontal TBI, 2.25 m/sec impact), or unilateral sensorimotor cortex contusions (lateral TBI, 3.22 m/sec impact) at 12 months of age and were tested throughout the next 12 months. Cognitive deficits were more robust and more enduring than sensorimotor deficits for both lateral TBI and frontal TBI groups. Lateral TBI rats exhibited transient deficits in the forelimb placing and in the rotarod test of motor/ambulatory function, but cognitive deficits were apparent throughout the 12-month postsurgery period on tests of spatial learning and memory including: (l)reacquisition of a working memory version of the radial arm maze 6–7 months post-TBI, (2) performance in water maze probe trials 8 months post-TBI, and (3) repeated acquisition of the Morris water maze 8 and 11 months post-TBI. Frontal TBI rats exhibited a different pattern of deficits, with the most robust deficits in tests of attention/orientation such as: (1) the delayed nonmatching to position task (even with no delays) 1–11 weeks post-TBI, (2) the repeated acquisition version of the water maze—especially on the first "information" trial 8 months post-TBI, (3) a test of sensorimotor neglect or inattention 8.5 months post-TBI, and (4) a DRL20 test of timing and/or sustained attention 11 months after surgery. These results suggest that long-term behavioral deficits can be detected in rodent models of TBI, that cognitive deficits seem to be more robust than sensorimotor deficits, and that different TBI impact sites produce dissociable patterns of cognitive deficits in rats.